Sharon Goswami Featured in “Legal Spotlight” Series on Bloomberg Law
April 29, 2020
On April 20, 2020, Cravath partner Sharonmoyee Goswami was featured in Bloomberg Law’s “Legal Spotlight” series. Sharon discussed how her background in chemical engineering, engineering biology and materials science informs her litigation practice, including in cases dealing with biotechnology, medical devices and environmental issues.
“Almost everything that I’ve studied, in kind of surprising ways, has come up in my legal career,” Sharon said of her chemical engineering background.
Related Practices & Industries
People
- Photo
-
-
J.D., 2012, New York University School of LawOrder of the Coif, magna cum laude
-
B.S.E., 2009, Princeton University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
DRIT Wins Patent Licensing Dispute
On September 18, 2018, a Delaware jury returned a unanimous verdict in favor of Cravath client DRIT LP (“DRIT”) in a patent licensing dispute with Glaxo Group Limited and Human Genome Sciences, Inc. (“GSK”). The jury found that GSK had breached the implied covenant of good faith and fair dealing when it statutorily disclaimed a U.S. patent covering GSK’s lupus drug, Benlysta® to cut off its obligation to pay royalties to DRIT on U.S. sales of Benlysta®. The case arose out of a 2008 agreement under which GSK agreed to pay Biogen Inc. royalties on sales of Benlysta® in exchange for Biogen’s rights to certain intellectual property covering the medication. In 2012, DRIT, an investment vehicle managed by Cravath client DRI Capital, purchased Biogen’s royalty stream. In April 2015, after making royalty payments to DRIT for three years, GSK voluntarily disclaimed the royalty‑bearing patent and ceased paying royalties to DRIT. The matter was tried for six days before a jury in the Delaware Superior Court.
